Unani medicine takes an individualized and predictive approach towards health promotion and prevention, placing special emphasis on determining temperament and recognizing prodromal symptoms as early warning signals.
Symptomatic relief, an improvement of liver function tests towards normal and decreased hepatitis B virus (HBV) DNA could be the result of Majoon Dabeed-ul-ward's hepatoprotective properties containing Rosa damescene and Chicory seed (Cichorium intybus), among other herbs mentioned in classical texts that possess this property.
Unani medicines may help patients with cirrhosis avoid complications by strengthening and restoring the liver to its original size, while simultaneously decreasing inflammation and improving hepatic function.
Hepatocellular carcinoma, the leading cause of death among those with advanced cirrhosis, can be prevented using herbal medicines and regular health screenings such as pneumovax vaccinations and flu vaccinations. These steps include abstaining from alcohol use and receiving vaccinations against Hepatitis A & B along with regular health checks like pneumovax shots & fall flu shots.
Unani medicine offers an abundance of herbs and compound formulations that can effectively treat NAFLD. These medications have many diverse actions such as Musakhkhin (calorific), Mudirr (diuretic) and Muqawwi-i-Jigar (hepatoprotective). Unani medicines may help in slowing or stopping progression from NAFLD to cirrhosis as well as reverseing hepatic fibrosis with their antioxidant, hypolipidemic and anti-inflammatory properties Arq Kasni.
Unani medicines possess potency against fibrosis as well as being liver protectors and regenerators agents, protecting from damage while simultaneously reducing inflammation (anti-inflammatory action) which often precedes or accompanies fibrosis.
Non-Alcoholic Fatty Liver Disease (NAFLD) is an ever-increasing global health crisis and the primary source of hepatocellular carcinoma and liver transplantation needs. Conventional pharmaceutical therapies do not work well when it comes to managing NAFLD.
Unani medicine offers many single and compound formulations that can serve as effective hepatoprotective agents, acting as Muqawwi Jigar or Liver Tonics due to their Musakhkhin (calorific), Mudirr (diuretics), and Mufattih (deobstruent) actions. Furthermore, Unani medicines have shown promising immune modulating activities by augmenting innate immunity while suppressing adaptive immunity - this case series illustrates this potential by showing how combinations of Unani medications can reverse hepatic fibrosis in patients suffering decompensated cirrhosis while improving quality of life and relieving symptoms such as headache.
Unani physicians have used several herbal drugs for treating liver conditions. One promising treatment option is Cymbopogon martinii (Roxb.) Wats., more commonly known by its Arabic name Izkhar; this natural herb has long been utilized by Unani medicine and scientific studies have confirmed its hepatoprotective properties.
Liver disease is an alarming medical condition with limited therapeutic options, many of which cause harmful side-effects or even hepatotoxicity.
The liver is an integral component of human anatomy with four natural faculties of digestion, concoction, absorption and excretion. The normal temperament of the liver is hot and moist; this may change due to diet or excessive fat consumption. Unani medicine has the power to regenerate liver tissue while stopping progression of cirrhosis progression and alleviate associated symptoms; this case series showcases successful treatment of decompensated cirrhosis with Unani therapy warranting further clinical trials.
Herbal remedies for liver disease have long been considered an effective therapy. Herbs contain anti-hepatotoxic agents and help in the reduction of scar tissue formation; furthermore, herbs may even assist in improving liver size.
Unani medicine offers an impressive collection of single herbs and compound formulations for treating NAFLD, with anti-oxidative, hypolipidemic, hepatoprotective and other hepatoprotective activities as well as anti-inflammatory, analgesic and antipyretic properties.
Case series of five patients with decompensated cirrhosis and portal hypertension who received Unani therapy showed marked improvements in symptoms, quality of life (EQ5D), Child-Pugh score and bilirubin levels after 12 weeks of Unani Herbal Medicine in Pakistan. Repeated FibroScan analysis on these same patients also showed reduced levels of fibrosis from median 21.1kPa and 302dB/m down to 14.4 kPa and 201 dB/m; this may be explained by anti-fibrotic action of Unani therapy as well as liver regeneration and anti-fibrotic action by these treatments; however further clinical trials will need to validate these findings.